Menstrual and Contraceptive Issues among Young Women with Developmental Delay: A Retrospective Review of Cases at the Hospital for Sick Children, Toronto

Dizon, Christine D.; Allen, Lisa; Ornstein, Melanie

doi:10.1016/j.jpag.2005.03.002

Cited by 68 publications

(66 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…229 Menstrual hygiene also may present a special problem for adolescents with motility and transfer difficulties, as well as for those with behavioral and developmental disabilities. 230 Menstrual control and suppression is commonly achieved with COCs, transdermal patches, DMPA, and levonorgestrel IUDs. 77,231,232 Continuous or extended cycles of COCs is a common approach, 231,232 and there are reports of successful use of 52-mg levonorgestrel IUDs in adolescent patients.…”

Section: Adolescents With Disabilitiesmentioning

confidence: 99%

Contraception for Adolescents

Ott

Sucato²

2014

Pediatrics

244

133

View full text Add to dashboard Cite

A working knowledge of contraception will assist the pediatrician in both sexual health promotion as well as treatment of common adolescent gynecologic problems. Best practices in adolescent anticipatory guidance and screening include a sexual health history, screening for pregnancy and sexually transmitted infections, counseling, and if indicated, providing access to contraceptives. Pediatricians’ long-term relationships with adolescents and families allow them to help promote healthy sexual decision-making, including abstinence and contraceptive use. Additionally, medical indications for contraception, such as acne, dysmenorrhea, and heavy menstrual bleeding, are frequently uncovered during adolescent visits. This technical report provides an evidence base for the accompanying policy statement and addresses key aspects of adolescent contraceptive use, including the following: (1) sexual history taking, confidentiality, and counseling; (2) adolescent data on the use and side effects of newer contraceptive methods; (3) new data on older contraceptive methods; and (4) evidence supporting the use of contraceptives in adolescent patients with complex medical conditions.

show abstract

Section: Adolescents With Disabilitiesmentioning

confidence: 99%

Contraception for Adolescents

Ott

Sucato²

2014

Pediatrics

244

133

View full text Add to dashboard Cite

show abstract

“…The disproportionately high use of Depo-Provera Ò demonstrated in this research and elsewhere [18,19], leads one to question whether this is always done in practice. Depo-Provera Ò is not commonly used by women in the general population, only by some 3% in the UK [20].…”

Section: Consent To Sexmentioning

confidence: 93%

Prescribing Contraception to Women with Intellectual Disabilities: General Practitioners’ Attitudes and Practices

McCarthy

2011

Sex Disabil

View full text Add to dashboard Cite

The challenges of providing appropriate reproductive healthcare to women with intellectual disabilities are set within the context of a primary health care system. The rationale for this study was to explore the prescribing practices and attitudes of General Practitioner's (GP) when women with intellectual disabilities come to them for contraception. The data reported in this paper come from a cross-sectional postal questionnaire survey conducted with 162 GPs across two counties in England. The majority of respondents had 10 or fewer women with intellectual disabilities of child bearing age on their caseloads. The most commonly prescribed methods of contraception were the Pill (39.7%) and depot medroxyprogesterone acetate (DMPA), (34.2%). The difficulties faced by GPs in determining 'best interests' are explored, as are the issues related to the women's capacity to consent to sex.

show abstract

“…Given by deep intramuscular injection at a dose of 150 mg every 12 weeks, DMPA is commonly used in those with learning disabilities. [2][3][4] Amenorrhoea is usually achieved, but spotting or some breakthrough bleeding may occur in up to 49% of patients. 2 The major concern regarding DMPA use in this population is the well established association between DMPA use and decreased acquisition of bone mineral density (BMD) in adolescent girls.…”

Section: Therapeutic Optionsmentioning

confidence: 99%

“…[2][3][4] Amenorrhoea is usually achieved, but spotting or some breakthrough bleeding may occur in up to 49% of patients. 2 The major concern regarding DMPA use in this population is the well established association between DMPA use and decreased acquisition of bone mineral density (BMD) in adolescent girls. Adolescence is a crucial period of bone mineralisation leading to the achievement of peak bone mass Abbreviations: BMD, bone mineral density; COC, combined oral contraceptives; DMPA, depot medroxyprogesterone acetate injections; GnRH, gonadotrophin-releasing hormone; LNG-IUS, levonorgestrel intrauterine system; POP, progesterone only contraceptive pill in early adulthood.…”

Section: Therapeutic Optionsmentioning

confidence: 99%